Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor. Intracellular half-life is 39 h.
声明:
如果该化合物涉及专利保护,请勿作为商业目的使用,且仅供实验分析及研究之目的;如被销售到构成专利侵权的国家,则相应的一切风险将由买方承担。